Review: taking Coumadin and Lidocaine viscous together


Summary

Drug interactions are reported among people who take Coumadin and Lidocaine viscous together. This review analyzes the effectiveness and drug interactions between Coumadin and Lidocaine viscous. It is created by eHealthMe based on reports of 1,335 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Lidocaine viscous >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 80,735 users)

Lidocaine Viscous

Lidocaine viscous has active ingredients of lidocaine hydrochloride. It is often used in local anaesthesia. (latest outcomes from Lidocaine viscous 121 users)

On Aug, 20, 2016

1,335 people who take Coumadin, Lidocaine Viscous are studied.


Number of reports submitted per year:

Coumadin and Lidocaine viscous drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Lidocaine Viscous:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 33.0% - (1 of 3 people)
  • male: 33.0% - (1 of 3 people)
Lidocaine Viscous:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 2 people)
Lidocaine Viscous:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • pain
  • renal failure
  • anxiety
  • fall
  • injury
  • anhedonia
  • pyrexia
  • depression
  • death
  • malnutrition
1 - 6 months:
  • gastrointestinal haemorrhage
  • pancytopenia
  • anaemia
  • cellulitis
  • coagulopathy
  • death
  • haematochezia
  • pain
  • abdominal discomfort
  • alopecia
6 - 12 months:
  • abdominal pain
  • cellulitis
  • hidradenitis
  • pneumonitis
  • pneumonia
  • biliary tract infection
  • cardiac failure
  • cardio-respiratory arrest
  • cholelithiasis
  • cholestasis
1 - 2 years:
  • acute myeloid leukaemia
  • anaemia
  • hypotension
  • malignant melanoma
  • nephrogenic systemic fibrosis
  • adrenal insufficiency
  • ascites
  • atrial fibrillation
  • back pain
  • basal cell carcinoma
2 - 5 years:
  • acute myeloid leukaemia
  • dyspnoea
  • malignant melanoma
  • arrhythmia
  • asthma
  • atrial fibrillation
  • back pain
  • basal cell carcinoma
  • bradycardia
  • c-reactive protein increased
5 - 10 years:
  • aggression
  • anxiety
  • depression
  • intentional overdose
  • loss of consciousness
  • suicide attempt
10+ years:
  • anhedonia
  • anxiety
  • death
  • depression
  • emotional distress
  • fear
  • injury
  • loss of consciousness
  • pain
  • renal failure
not specified:
  • pain
  • anxiety
  • dyspnoea
  • osteonecrosis of jaw
  • injury
  • back pain
  • osteoarthritis
  • anaemia
  • asthenia
  • nausea

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • osteonecrosis of jaw
  • back pain
  • injury
  • fall
  • dyspnoea
  • osteoarthritis
  • oedema peripheral
  • depression
male:
  • pain
  • anxiety
  • anaemia
  • dyspnoea
  • nausea
  • pyrexia
  • injury
  • hypotension
  • asthenia
  • bone disorder

Most common drug interactions by age *:

0-1:
  • blood pressure decreased
  • epilepsy
  • overdose
  • somnolence
2-9:
  • collapse
  • hypoxic encephalopathy
  • pulse absent
  • pyrexia
  • torsade de pointes
  • ventricular fibrillation
  • atrioventricular block complete
  • cardiac pacemaker malfunction
  • sinus tachycardia
  • ventricular tachycardia
10-19:
  • anxiety
  • pain
  • emotional distress
  • general physical health deterioration
  • injury
  • abdominal mass
  • abdominal pain
  • abdominal pain upper
  • actinomycosis
  • albumin globulin ratio decreased
20-29:
  • bronchitis
  • cardiac failure congestive
  • influenza like illness
  • renal failure
  • urinary tract infection
  • vomiting
  • presyncope
  • atrial fibrillation
  • cholecystitis
  • insomnia
30-39:
  • pain
  • anxiety
  • abdominal pain
  • cellulitis
  • stress
  • arthralgia
  • gait disturbance
  • hidradenitis
  • myalgia
  • oedema peripheral
40-49:
  • pain
  • bone disorder
  • osteonecrosis of jaw
  • oedema peripheral
  • intervertebral disc degeneration
  • cataract
  • back pain
  • abdominal pain
  • pain in extremity
  • osteoarthritis
50-59:
  • pain
  • anxiety
  • injury
  • osteonecrosis of jaw
  • fall
  • hypoaesthesia
  • dyspnoea
  • neuropathy peripheral
  • osteoarthritis
  • anaemia
60+:
  • pain
  • anxiety
  • injury
  • dyspnoea
  • anaemia
  • asthenia
  • nausea
  • emotional distress
  • osteoarthritis
  • fall

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Lidocaine viscous?

Can you answer these questions?

More questions for: Coumadin, Lidocaine viscous

You may be interested in these reviews

More reviews for: Coumadin, Lidocaine viscous

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Lidocaine viscous (lidocaine hydrochloride) is often used to treat local anaesthesia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.